Common antioxidant enzyme catalase as COVID-19 treatment
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
No hay comentarios:
Publicar un comentario